MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEIBMAN, K. C.
Right arrow Articles by ESTABROOK, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEIBMAN, K. C.
Right arrow Articles by ESTABROOK, R. W.

Molecular Pharmacology, Vol 7, 26-32, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Extraction with Isooctane upon the Properties of Liver Microsomes

KENNETH C. LEIBMAN 1 and RONALD W. ESTABROOK 1

1 Department of Pharmacology and Therapeutics, University of Florida Medical School, Gainesville, Florida 32601, and Department of Biochemistry, University of Texas Southwestern Medical School, Dallas, Texas 75235

When rat liver microsomes were extracted with isooctane (2,2,4-trimethylpentane), the resultant preparation was essentially devoid of the ability to produce a type I difference spectrum upon addition of hexobarbital. At high concentrations of hexobarbital, a type II spectral change was obtained with the extracted microsomes. The type II interaction of aniline with isooctane-extracted microsomes was not enhanced in the presence of hexobarbital, as it was in the case of untreated microsomes. Hexobarbital binding to cytochrome P-450 of untreated microsomes was inhibited in the presence of isooctane, but the amount of residual isooctane in the extracted microsomes was not sufficient to explain the loss of hexobarbital-binding activity. The isooctane extracts contained phosphatidylcholine and phosphatidylethanolamine. The results are discussed in terms of a model in which the type I binding form of cytochrome P-450 involves an association of hemoprotein with a phospholipid, or with some other microsomal constituent in an interaction involving phosphatides.

Submitted on August 5, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics